Cypress Capital Group Regeneron Pharmaceuticals, Inc. Transaction History

Cypress Capital Group

$827 Million
Q2 2024

A detailed history of Cypress Capital Group transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cypress Capital Group holds 351 shares of REGN stock, worth $365,791. This represents 0.04% of its overall portfolio holdings.

Number of Shares

351

Previous 392 10.46%

Holding current value

$365,791

Previous $377,000 2.39%

% of portfolio

0.04%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$883.2 - $1071.19 $36,211 - $43,918	-41 Reduced 10.46%	351 $368,000
Q1 2024 May 08, 2024	SELL	$902.69 - $993.35 $911,716 - $1 Million	-1,010 Reduced 72.04%	392 $377,000
Q4 2023 Jan 24, 2024	SELL	$775.18 - $881.7 $7,751 - $8,817	-10 Reduced 0.71%	1,402 $1.23 Million
Q3 2023 Nov 02, 2023	SELL	$692.45 - $844.37 $206,350 - $251,622	-298 Reduced 17.43%	1,412 $1.16 Million
Q2 2023 Jul 26, 2023	BUY	$700.03 - $830.35 $41,301 - $48,990	59 Added 3.57%	1,710 $1.23 Million
Q1 2023 May 04, 2023	SELL	$680.49 - $826.97 $8,846 - $10,750	-13 Reduced 0.78%	1,651 $1.36 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $54,353 - $59,012	77 Added 4.85%	1,664 $1.2 Million
Q3 2022 Nov 04, 2022	BUY	$573.97 - $724.32 $910,890 - $1.15 Million	1,587 New	1,587 $1.09 Million
Q1 2021 Apr 14, 2021	SELL	$446.73 - $548.2 $318,518 - $390,866	-713 Closed	0 $0
Q4 2020 Jan 12, 2021	SELL	$478.3 - $607.98 $20,566 - $26,143	-43 Reduced 5.69%	713 $344,000
Q3 2020 Oct 08, 2020	BUY	$544.75 - $658.21 $17,432 - $21,062	32 Added 4.42%	756 $423,000
Q2 2020 Jul 10, 2020	BUY	$493.32 - $643.92 $93,237 - $121,700	189 Added 35.33%	724 $452,000
Q1 2020 Apr 08, 2020	SELL	$336.18 - $494.43 $41,350 - $60,814	-123 Reduced 18.69%	535 $261,000
Q4 2019 Jan 10, 2020	BUY	$274.13 - $376.51 $180,377 - $247,743	658 New	658 $247,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Regeneron Pharmaceuticals, Inc. Transaction History